Geneia focuses on COVID-19 and AI at HIMSS20 Digital
April 9, 2020
Harrisburg, PA – Geneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, is focused on COVID-19 and the near-term potential and possibilities of artificial intelligence (AI) at HIMSS20 Digital.
“As expected, early data shows physician practices are challenged to manage the onslaught of patient inquiries. A recent survey by the Primary Care Collaborative found nearly eight in 10 (79.4 percent) report their primary care practices ae under ‘severe’ or ‘close to severe’ strain due to COVID-19,” said Heather Lavoie, president and CEO, Geneia. “We’re pleased to share a free, lightweight version of Geneia’s Theon® Platform for Care Management with hospitals, healthcare systems and physician practices seeking to quickly and easily triage patients seeking COVID-19 information, resources and care.”
Geneia On-Demand Presentations at HIMSS Digital
Micro-demo: Geneia’s Theon® Platform for Care Management of COVID-19 Patients
A four-minute demo of how healthcare organizations can use the platform to triage, outreach to and engage patients for COVID-19 care coordination.
AI Fireside Chat: AI & Future Cost Savings
Fred Rahmanian, Geneia chief analytics and technology officer and leader of the Geneia Data Intelligence Lab, moderates a robust conversation about using AI to reduce future healthcare costs with panelists:
- Josh Newman, MD, Salesforce Chief Medical Officer
- Bharat Rao, Partner/Leader Data Analytics, KPMG Healthcare Life Sciences
- Aneesh Chopra, Care Journey President and former US CTO
To learn more about Geneia’s COVID-19 solution, visit: https://content.geneia.com/2020/covid-19-care-management-for-healthcare-professionals/index.html.
Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.